FrederickG.HaydenMD
Infectious Disease • Charlottesville, VAProfessor Emeritus, Department of Medicine, University of Virginia School of Medicine
Dr. Hayden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
345 Crispell Drive, MR-6
Charlottesville, VA 22908Phone+1 434-924-5059- Is this information wrong?
Education & Training
University of RochesterFellowship, Infectious Disease, 1976 - 1978- University of RochesterResidency, Internal Medicine, 1973 - 1976
Stanford University School of MedicineClass of 1973
Certifications & Licensure
VA State Medical License 1978 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1992
Publications & Presentations
PubMed
- 1 citationsOral Favipiravir Exposure and Pharmacodynamic Effects in Outpatient Adults with Acute Influenza.Frederick G Hayden, Robert P Lenk, Carol Epstein, Lih Lisa Kang> ;The Journal of Infectious Diseases. 2023 Sep 22
- Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levels.Yaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, Mashan L Abdullah, Haya A Aljami, Hanan H Balkhy, Majed Al Jeraisy, Yasser Mandourah, Sameera AlJohani, Shmeylan Al Ha...> ;Scientific Reports. 2022 Oct 28
- 4 citationsFavipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.Frederick G Hayden, Robert P Lenk, Lucille Stonis, Catherine Oldham-Creamer, Lih Lisa Kang, Carol Epstein> ;The Journal of Infectious Diseases. 2022 Nov 11
- Join now to see all
Journal Articles
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19Frederick Hayden, MD, The New England Journal of Medicine
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and AdolescentsFrederick Hayden, MD, The New England Journal of Medicine
Authored Content
- Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory SyndromeOctober 2020
Press Mentions
Mixed Bag for Antiviral Favipiravir in FluMay 31st, 2022- Pandemic Fraud: Fauci Pushed US to Spend $1.5 Billion on Big Pharma Drug That Has No Proven BenefitsJuly 24th, 2021
- Covid-19: Lopinavir-Ritonavir Combo Falls Short—AgainOctober 7th, 2020
- Join now to see all
Grant Support
- Intravenous Zanamir In Experimental InfluenzaNational Center For Research Resources1998–1999
- Rimantadine In Treating Influenza A Virus In Adult PatientsNational Center For Research Resources1989
- Prophylactic Efficacy Of Interferon-Beta 17 Serine In Naturally Acquired ColdsNational Center For Research Resources1988–1989
- Multiple Dose Pharmacokinetics Of Rimantadine In Older VolunteersNational Center For Research Resources1987–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
